DHR
Price
$196.31
Change
+$4.24 (+2.21%)
Updated
Apr 23 closing price
Capitalization
184.93B
96 days until earnings call
QGEN
Price
$42.32
Change
-$0.02 (-0.05%)
Updated
Apr 23 closing price
Capitalization
9.52B
13 days until earnings call
Ad is loading...

DHR vs QGEN

Header iconDHR vs QGEN Comparison
Open Charts DHR vs QGENBanner chart's image
Danaher
Price$196.31
Change+$4.24 (+2.21%)
Volume$6.49M
Capitalization184.93B
Qiagen
Price$42.32
Change-$0.02 (-0.05%)
Volume$1.37M
Capitalization9.52B
DHR vs QGEN Comparison Chart
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. QGEN commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Buy and QGEN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (DHR: $196.31 vs. QGEN: $42.32)
Brand notoriety: DHR and QGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 141% vs. QGEN: 103%
Market capitalization -- DHR: $184.93B vs. QGEN: $9.52B
DHR [@Medical Specialties] is valued at $184.93B. QGEN’s [@Medical Specialties] market capitalization is $9.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 0 FA rating(s) are green whileQGEN’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 0 green, 5 red.
  • QGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, QGEN is a better buy in the long-term than DHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 6 TA indicator(s) are bullish while QGEN’s TA Score has 5 bullish TA indicator(s).

  • DHR’s TA Score: 6 bullish, 2 bearish.
  • QGEN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DHR is a better buy in the short-term than QGEN.

Price Growth

DHR (@Medical Specialties) experienced а +2.96% price change this week, while QGEN (@Medical Specialties) price change was +1.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

DHR is expected to report earnings on Jul 29, 2025.

QGEN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than QGEN($9.52B). DHR has higher P/E ratio than QGEN: DHR (43.86) vs QGEN (27.85). QGEN YTD gains are higher at: -2.057 vs. DHR (-14.350). DHR has higher annual earnings (EBITDA): 7.5B vs. QGEN (689M). DHR has more cash in the bank: 5.86B vs. QGEN (1.06B). QGEN has less debt than DHR: QGEN (1.53B) vs DHR (19.5B). DHR has higher revenues than QGEN: DHR (23.9B) vs QGEN (1.97B).
DHRQGENDHR / QGEN
Capitalization185B9.52B1,944%
EBITDA7.5B689M1,088%
Gain YTD-14.350-2.057698%
P/E Ratio43.8627.85157%
Revenue23.9B1.97B1,216%
Total Cash5.86B1.06B554%
Total Debt19.5B1.53B1,273%
FUNDAMENTALS RATINGS
DHR vs QGEN: Fundamental Ratings
DHR
QGEN
OUTLOOK RATING
1..100
6019
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
5078
SMR RATING
1..100
7887
PRICE GROWTH RATING
1..100
6348
P/E GROWTH RATING
1..100
573
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (62) in the Medical Specialties industry is in the same range as QGEN (85). This means that DHR’s stock grew similarly to QGEN’s over the last 12 months.

DHR's Profit vs Risk Rating (50) in the Medical Specialties industry is in the same range as QGEN (78). This means that DHR’s stock grew similarly to QGEN’s over the last 12 months.

DHR's SMR Rating (78) in the Medical Specialties industry is in the same range as QGEN (87). This means that DHR’s stock grew similarly to QGEN’s over the last 12 months.

QGEN's Price Growth Rating (48) in the Medical Specialties industry is in the same range as DHR (63). This means that QGEN’s stock grew similarly to DHR’s over the last 12 months.

QGEN's P/E Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for DHR (57). This means that QGEN’s stock grew somewhat faster than DHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRQGEN
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
51%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bullish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 11 days ago
56%
Declines
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
58%
View a ticker or compare two or three
Ad is loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CLOU20.140.67
+3.44%
Global X Cloud Computing ETF
SPBC35.360.65
+1.87%
Simplify US Equity PLUS Bitcoin Stgy ETF
GSEE43.68N/A
N/A
Goldman Sachs MarketBeta Emer Mkt Eq ETF
SMIG27.45-0.04
-0.15%
Bahl & Gaynor Sm/Md Cp Inc Gr ETF
XLP81.77-0.47
-0.57%
The Consumer Staples Sel SectSPDR® ETF

QGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with TMO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
-0.05%
TMO - QGEN
60%
Loosely correlated
-0.71%
A - QGEN
57%
Loosely correlated
+2.13%
RVTY - QGEN
56%
Loosely correlated
+1.46%
DHR - QGEN
55%
Loosely correlated
+2.21%
WAT - QGEN
51%
Loosely correlated
+1.25%
More